Lighthouse Investment Partners LLC Has $4.85 Million Stock Holdings in The Chemours Company $CC

Lighthouse Investment Partners LLC decreased its position in shares of The Chemours Company (NYSE:CC) by 32.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 306,187 shares of the specialty chemicals company’s stock after selling 144,757 shares during the period. Lighthouse Investment Partners LLC’s holdings in Chemours were worth $4,850,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. MTM Investment Management LLC bought a new stake in shares of Chemours in the second quarter valued at about $27,000. Evelyn Partners Asset Management Ltd bought a new position in Chemours during the second quarter worth about $37,000. Hantz Financial Services Inc. raised its stake in Chemours by 334.2% in the 3rd quarter. Hantz Financial Services Inc. now owns 4,329 shares of the specialty chemicals company’s stock worth $69,000 after purchasing an additional 3,332 shares in the last quarter. Itau Unibanco Holding S.A. grew its position in Chemours by 102.3% during the second quarter. Itau Unibanco Holding S.A. now owns 7,149 shares of the specialty chemicals company’s stock worth $82,000 after buying an additional 3,615 shares in the last quarter. Finally, CWM LLC increased its stake in Chemours by 32.4% during the 3rd quarter. CWM LLC now owns 5,682 shares of the specialty chemicals company’s stock worth $90,000 after acquiring an additional 1,392 shares during the period. Institutional investors and hedge funds own 76.26% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have weighed in on CC. JPMorgan Chase & Co. lifted their price objective on Chemours from $13.00 to $17.00 and gave the company a “neutral” rating in a report on Monday, February 23rd. Morgan Stanley increased their target price on Chemours from $15.00 to $17.00 and gave the stock an “equal weight” rating in a report on Monday, February 23rd. Mizuho raised their price target on Chemours from $17.00 to $21.00 and gave the stock an “outperform” rating in a research report on Thursday, March 5th. UBS Group boosted their price target on Chemours from $18.00 to $23.00 and gave the company a “buy” rating in a research note on Monday, February 23rd. Finally, Truist Financial increased their price objective on shares of Chemours from $18.00 to $21.00 and gave the stock a “buy” rating in a research note on Wednesday, January 21st. Five analysts have rated the stock with a Buy rating, five have assigned a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $18.40.

Chemours Stock Up 0.4%

NYSE CC opened at $17.65 on Tuesday. The business has a fifty day moving average price of $17.05 and a two-hundred day moving average price of $14.85. The company has a debt-to-equity ratio of 16.33, a current ratio of 1.78 and a quick ratio of 0.85. The Chemours Company has a fifty-two week low of $9.13 and a fifty-two week high of $21.85. The stock has a market capitalization of $2.65 billion, a PE ratio of -7.11 and a beta of 1.60.

Chemours (NYSE:CC) last issued its quarterly earnings results on Thursday, February 19th. The specialty chemicals company reported $0.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.04. Chemours had a positive return on equity of 41.75% and a negative net margin of 6.41%.The company had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.33 billion. During the same quarter last year, the company posted $0.09 EPS. The company’s revenue for the quarter was down 2.2% compared to the same quarter last year. Equities analysts expect that The Chemours Company will post 2.03 earnings per share for the current fiscal year.

Chemours Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 13th. Investors of record on Friday, February 27th were paid a $0.0875 dividend. The ex-dividend date of this dividend was Friday, February 27th. This represents a $0.35 annualized dividend and a yield of 2.0%. Chemours’s dividend payout ratio (DPR) is -14.11%.

About Chemours

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.